New Breakthrough Device test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus Basel, 8 September 2020 - ...
FDA granted de novo class II for cobas EBV test following the agency’s Breakthrough Device designation Accurate monitoring of Epstein-Barr virus DNA levels is critical, as they are associated with a ...
Immunocompromised transplant patients are at risk of major complications when infected with BK virus cobas BKV test addresses critical need for hospitals and laboratories to have standardised and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results